Scarica l'app Stockscreener
6.95
6.33%
-0.47
Dopo l'orario di chiusura:
6.81
-0.14
-2.01%
Precedente Chiudi:
$7.42
Aprire:
$7.42
Volume 24 ore:
55,319
Relative Volume:
0.43
Capitalizzazione di mercato:
$62.32M
Reddito:
$49.09M
Utile/perdita netta:
$-52.15M
Rapporto P/E:
-10.69
EPS:
-0.65
Flusso di cassa netto:
$-45.93M
1 W Prestazione:
-11.24%
1M Prestazione:
+5.95%
6M Prestazione:
-37.23%
1 anno Prestazione:
-79.07%
Intervallo 1D:
$6.81
$7.565
Intervallo di 1 settimana:
$6.81
$7.9722
Portata 52W:
$3.436
$34.40
Biodesix Inc Stock (BDSX) Company Profile
Nome
Biodesix Inc
Settore
Industria
Telefono
303-417-0500
Indirizzo
919 WEST DILLON ROAD, LOUISVILLE
Confronta BDSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
6.95 | 62.32M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-07-26 | Iniziato | Craig Hallum | Buy |
| 2024-05-13 | Iniziato | TD Cowen | Buy |
| 2024-05-03 | Iniziato | Lake Street | Buy |
| 2021-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | Iniziato | BTIG Research | Buy |
| 2020-11-23 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-23 | Iniziato | Morgan Stanley | Overweight |
| 2020-11-23 | Iniziato | William Blair | Outperform |
Mostra tutto
Biodesix Inc Borsa (BDSX) Ultime notizie
Will breakout in Biodesix Inc. lead to full recoveryInsider Selling & Real-Time Stock Movement Alerts - newser.com
Can Biodesix Inc. stock rebound after recent weaknessM&A Rumor & Safe Swing Trade Setups - newser.com
Biodesix Inc.’s volatility index tracking explainedJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
Biodesix, Inc. Announces Educational Presentations and Activities at 2025 CHEST Annual Meeting in Chicago - Quiver Quantitative
Is Biodesix Inc. stock a bargain at current levelsJuly 2025 Market Mood & AI Forecasted Entry/Exit Points - newser.com
Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting - GlobeNewswire
1,000 Patients: Biodesix Presents Interim CLARIFY Results at CHEST, Study Plans Up to 4,000 - Stock Titan
Can Biodesix Inc. stock outperform in 2025 bull market2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
What recovery options are there for Biodesix Inc.Dollar Strength & Long-Term Growth Portfolio Plans - newser.com
Order flow analysis tools used on Biodesix Inc.2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Leading vs lagging indicators on Biodesix Inc. performanceWeekly Loss Report & Weekly Breakout Stock Alerts - newser.com
It's Down 30% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks - 富途牛牛
Biodesix Implements Reverse Stock Split on September 15 - MSN
What the charts say about Biodesix Inc. todayJuly 2025 EndofMonth & Real-Time Sentiment Analysis - newser.com
News impact scoring models applied to Biodesix Inc.Weekly Trend Summary & Target Return Focused Picks - newser.com
Is Biodesix Inc. stock bottoming out2025 Dividend Review & Risk Controlled Daily Trade Plans - newser.com
Biodesix's (BDSX) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
How to read the order book for Biodesix Inc.Layoff News & Scalable Portfolio Growth Methods - newser.com
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Biodesix Unveils October Lung Health Events in Colorado - GlobeNewswire
3 October Lung Health Events: Biodesix Partners with APAPP, Go2 & American Lung Association in Colorado - Stock Titan
Why retail investors pile into Biodesix Inc. stockEarnings Overview Summary & Advanced Technical Signal Analysis - newser.com
Market reaction to Biodesix Inc.’s recent newsEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
What Fibonacci levels say about Biodesix Inc. reboundWeekly Trade Analysis & Verified Momentum Watchlists - newser.com
Trend analysis for Biodesix Inc. this weekCPI Data & Fast Gaining Stock Strategy Reports - newser.com
Can technical indicators confirm Biodesix Inc.’s reversalTrade Ideas & Weekly Top Gainers Trade List - newser.com
Understanding Biodesix Inc.’s price movementAnalyst Upgrade & Smart Investment Allocation Insights - newser.com
Biodesix Regains Nasdaq Compliance with Bid Price - TipRanks
What MACD signals say about Biodesix Inc.Earnings Risk Report & Fast Gain Stock Tips - newser.com
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Update - MarketBeat
Biodesix (BDSX) Price Target Increased by 1,900.00% to 35.70 - Nasdaq
Biodesix Inc Azioni (BDSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Biodesix Inc Azioni (BDSX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SCHULER JACK W | Director |
Sep 17 '25 |
Buy |
6.04 |
15,317 |
92,571 |
1,235,644 |
| SCHULER JACK W | Director |
Sep 18 '25 |
Buy |
6.17 |
3,056 |
18,854 |
1,238,700 |
| SCHULER JACK W | Director |
Aug 29 '25 |
Buy |
0.43 |
3,488,372 |
1,500,000 |
24,406,546 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Aug 13 '25 |
Sale |
0.42 |
988 |
411 |
250,794 |
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
| O'Kane Kieran | Chief Commercial Officer |
Aug 13 '25 |
Sale |
0.42 |
476 |
198 |
140,065 |
| Pestano Gary Anthony | Chief Development Officer |
Aug 13 '25 |
Sale |
0.42 |
442 |
184 |
157,878 |
| Vazquez Chris | Chief Accounting Officer |
Aug 13 '25 |
Sale |
0.42 |
228 |
95 |
18,375 |
| SCHULER JACK W | Director |
May 16 '25 |
Buy |
0.27 |
4,000,000 |
1,070,000 |
20,194,935 |
| SCHULER JACK W | Director |
May 19 '25 |
Buy |
0.34 |
723,239 |
246,624 |
20,918,174 |
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):